Fig. 7.
![Fig. 7. PBL were activated with PHA (5 μg/mL) for 3 days. Viable cells were then treated by antibodies MoAb90 (10 μg/mL), YTH862 (10 μg/mL), or anti-Fas MoAb CH11 (1 μg/mL) alone or in association and measurements of apoptosis were performed as in Fig 6. In parallel, CD45RA and CD45RO phenotype after 3 days of culture was evaluated by FACS analysis (CD45RA+ 22 [2.4%], CD4RO+ 32 [0.5%], CD45RA+RO+ 32 [0.5%]) (SEM in brackets).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/90/9/10.1182_blood.v90.9.3629/4/bl_0035f7.jpeg?Expires=1724236181&Signature=eEwGPHWNWboV4IIy8guoKlcdnMnJQED-TMCn4Kt8oBalmm0~CVx8jUXPSXzxexhSPti8eclfcx1HF3uQ1-YFDA65DClVRCkjzqD8u41NjK9h2rmPagrwT-Uuz1vDmapSmw2GyTtpkP0rgXucrhHdzYJ7xMqlfHpPyQGKWeyTjQwMJM4xpWd4~M5VDuvECZgMKLfNjszHIJPLxwd7Yi9VTcjxa2xRALmRWcL-F~LF0Es5P0mmxYc63PpzOSXF372lyFKgWc0l3MTUYNtWtqvAd46RfFWUt38j-6xiAxg3LqqYzU7emKdxE4Wsw3ZLtLQvM0UPi3I12r7R3qgS4IbqqA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
PBL were activated with PHA (5 μg/mL) for 3 days. Viable cells were then treated by antibodies MoAb90 (10 μg/mL), YTH862 (10 μg/mL), or anti-Fas MoAb CH11 (1 μg/mL) alone or in association and measurements of apoptosis were performed as in Fig 6. In parallel, CD45RA and CD45RO phenotype after 3 days of culture was evaluated by FACS analysis (CD45RA+ 22 [2.4%], CD4RO+ 32 [0.5%], CD45RA+RO+ 32 [0.5%]) (SEM in brackets).
